A solid water-dispersible composition of matter comprising at least one sugar, at least one polysaccharide and at least one surfactant and at least one lipophilic active pharmaceutical ingredient (API), the composition comprises a plurality of micrometric particles each comprising a plurality of lipophilic nanospheres with an average size in the range of 50-900 nm, the at least one lipophilic API is contained in the micrometric particles and is distributed inside and/or outside the lipophilic nanospheres at predetermined proportions, thereby providing an improved delivery of the at least one lipophilic API. A sugar particle comprising a porous sugar material and lipophilic nanospheres having average sizes between 50-900 nm so that the lipophilic nanospheres are comprised within the porous sugar material, the sugar particle comprises at least one edible sugar, at least one edible oil, at least one edible polysaccharide, at least one edible surfactant and at least one lipophilic API.

The current invention relates to a polymer-lipid microemulsion delivery system for drugs or antiviral compounds used in the treatment or inhibition of viral Acute Respiratory Distress Syndromes (ARDS), a process for producing the microemulsion delivery system, and to methods of use of the microemulsion delivery system for the treatment of ARDS.

This disclosure relates to a method of treating corona virus infections. More specifically disclosed are cannabinoids and derivatives effective for the treatment of RNA viral infections.

The present disclosure provides compositions and methods of use thereof for the treatment of skin diseases and disorders. The compositions comprise cannabidiol, or derivatives or pharmaceutical salts thereof. The formulations may also include glucosamine and antioxidant anti-inflammatory herbal extracts such as oleuropein and berberine in an emollient base.

The present invention provides apothecarial compositions and treatments for medical conditions and/or for cosmetic applications.

The present invention discloses compositions useful for treatment or prevention of Amyotrophic Lateral Sclerosis (ALS) or a related condition, and treatment methods thereof.

Therapeutic hydrogels in nonsurgical techniques to promote healing and regeneration of tissues whose structure and functions have been diminished due to chronic inflammatory disorders. More particularly, providing therapeutic and regenerative hydrogel compositions and their nonsurgical delivery to periodontal treatment sites to treat periodontal and peri-implant diseases. One delivery technique involves the injection of a sterile therapeutic biomimetic hyaluronic acid hydrogel tethered to at least one host modulating agent, such as tetrahydrocurcuminoids, THC, and at least one additional tissue regenerative agent, into the gingival connective tissue proper. The host modulating agent potentiates the periodontal tissue regeneration at the periodontal treatment site, while the biomimetic hyaluronic acid hydrogel serves in a dual capacity as a drug, a tissue regenerative agent carrier and as a biodegradable matrix around which the new connective tissue regenerates. Oral care gel and paste compositions may be used in a synergistic home-based oral care regimen.

The present application relates to use of cannabidiol in the preparation of a drug for treating coronavirus infections. The present invention specifically relates to cannabidiol, or a geometric isomer, pharmaceutically acceptable salt, solvate or hydrate thereof, or use of a pharmaceutical composition comprising any one or more of the above components in the preparation of a drug for preventing and/or treating diseases or infections caused by a coronavirus.

The present invention is in the field of a Food supplement for Alzheimer. Alzheimer's disease (AD), and likewise associated or similar discomforts, is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. The present invention provides a food supplement for preventing Alzheimer's disease, for delaying Alzheimer's disease, for decline of ageing, or combinations thereof.

The present disclosure provides compositions, systems, and methods for treating